Recent Advances in Cerebrospinal Cavernous Malformations
Author Information
Author(s): Laurel Rauschenbach, Philipp Dammann, Ulrich Sure
Primary Institution: University Hospital Essen, Essen, Germany
Hypothesis
An up-to-date review of the latest developments and controversies in the management of cerebrospinal cavernous malformations is necessary due to the rarity and heterogeneity of the disease.
Conclusion
Surgical resection remains the primary treatment for symptomatic or high-risk cerebrospinal cavernous malformations, with advances in techniques improving outcomes.
Supporting Evidence
- Knowledge about cerebrospinal cavernomas has grown considerably in recent years.
- Current guidelines recommend genetic testing in patients with multiple CMs when there is no associated DVA.
- Surgical resection is the gold standard for symptomatic or high-risk CMs.
Takeaway
Cavernous malformations in the brain can cause serious problems, but doctors are learning more about how to treat them safely and effectively.
Methodology
This narrative review synthesizes current strategies and treatment indications for CNS-CMs based on long-term clinical experience and recent literature.
Potential Biases
The review is based on observational studies, which may be limited by selection bias and short follow-up periods.
Limitations
The level of evidence remains limited due to the rarity and heterogeneity of the disease, and many questions are still unanswered.
Participant Demographics
The study includes a diverse group of patients with cerebrospinal cavernous malformations, but specific demographic details are not provided.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website